Self-funded, non-profit medical research organisation and charity LifeArc has announced today that it is to launch the Rare Disease Translational Challenge, which will inv
For the newest pharmaphorum podcast, editor-in-chief Jonah Comstock welcomes Dr Kristina Allikmets, SVP and head of R&D at Takeda’s plasma-derived therapies business unit.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho